Compound 1193
Identifiers
- Canonical SMILES:
Cn1ncc2c1nc(-c1ccc3sccc3c1)c1c2[nH]n(-c2cccc(F)c2)c1=O
- InChi:
InChI=1S/C22H14FN5OS/c1-27-21-16(11-24-27)20-18(22(29)28(26-20)15-4-2-3-14(23)10-15)19(25-21)13-5-6-17-12(9-13)7-8-30-17/h2-11,26H,1H3
- InChiKey:
DYAXPQONHBRWGO-UHFFFAOYSA-N
External links
![]() 168317863 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD80 / CD28 | 6.98 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 415.09 g/mol | |||
HBA | 6 | |||
HBD | 1 | |||
HBA + HBD | 7 | |||
AlogP | 5.13 | |||
TPSA | 63.05 | |||
RB | 2 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4890 | 6-(2-fluorobenzyl)-2,4-dimethyl-4,6-dihydro-5H-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5-one | DB07628 | |
0.4792 | Riociguat | DB08931 | |
0.4637 | Vericiguat | DB15456 | |
0.4581 | 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE | DB07218 | |
0.4522 | ATX-914 | DB12673 | |
0.4407 | Dilmapimod | DB12140 | |
0.4389 | 5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DB08534 | |
0.4328 | Tepotinib | DB15133 | |
0.4319 | Merestinib | DB12381 | |
0.4257 | N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide | DB08349 | |
0.4237 | Neflamapimod | DB07138 | |
0.4237 | Ravoxertinib | DB15281 | |
0.4204 | Risdiplam | DB15305 | |
0.4195 | ABT-288 | DB15192 | |
0.4170 | MK-6186 | DB12999 |